Fontem Ventures, owner of the global vape brand blu, responds to CDC update on US lung injuries connected with illicit vaping products11.11.19
Amsterdam – November 11th 2019 – Fontem Ventures welcomes the US Centers for Disease Controls (CDC) update that vitamin E acetate has been identified as present in 100% of tested samples from victims of lung injuries in the US.
Vitamin E acetate is not, and has never been, an ingredient in blu e-vapour products.
We also echo the CDC’s advice to adult vapers and smokers that they should not buy any vaping product, particularly those containing THC, “off the street” or from an informal source.
“All of our blu vaping products, their ingredients and the vapour produced undergo thorough scientific assessment prior to manufacture and sale. Our e-liquid ingredient selection is guided by toxicological principles and all our e-liquid ingredients undergo a rigorous assessment process. None of blu’s vaping products contain THC, vitamin E acetate, mineral oils or animal fats” said Dr Joe Thompson, Group Science and Regulatory Affairs Director. “blu has been an established business for over 10 years and our message to concerned vapers is that they should purchase vaping products from reputable brands and retailers and ensure that products are properly sealed, packaged and labelled.”
Fontem Ventures believes that pod-based vape systems offer the best opportunity to ensure that both the ingredients and the generated vapour aerosol fall within pre-defined and regulated standards. We support regulatory measures that limit the ability of users to alter the generated e-vapour aerosol and the ingredients that can be used within them.
About Fontem Ventures
Fontem Ventures B.V., is the e-vapour business behind blu. Headquartered in Amsterdam, Fontem Ventures’ purpose is to drive electronic vaping technology forward, delivering choice to smokers and vapers around the world. Fontem Ventures is a subsidiary of Imperial Brands plc.